Phathom Pharmaceuticals Stock Price on February 6, 2024
| PHAT Stock | USD 8.93 0.36 3.88% |
Below is the normalized historical share price chart for Phathom Pharmaceuticals extending back to October 25, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Phathom Pharmaceuticals stands at 8.93, as last reported on the 11th of December 2024, with the highest price reaching 8.93 and the lowest price hitting 8.93 during the day.
If you're considering investing in Phathom Stock, it is important to understand the factors that can impact its price. Phathom Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.18, which implies the firm had a -0.18% return per unit of risk over the last 3 months. Phathom Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Phathom Pharmaceuticals' Risk Adjusted Performance of (0.09), variance of 34.13, and Coefficient Of Variation of (698.13) to confirm the risk estimate we provide.
Stock Based Compensation is likely to gain to about 47.3 M in 2024, despite the fact that Total Stockholder Equity is likely to grow to (69.1 M). . Price To Sales Ratio is likely to drop to 549.29 in 2024. Price Earnings Ratio is likely to drop to -2.44 in 2024. Phathom Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 25th of October 2019 | 200 Day MA 12.2256 | 50 Day MA 13.8032 | Beta 0.718 |
Phathom |
Sharpe Ratio = -0.1754
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PHAT |
Estimated Market Risk
| 5.85 actual daily | 52 52% of assets are less volatile |
Expected Return
| -1.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.18 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Phathom Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Phathom Pharmaceuticals by adding Phathom Pharmaceuticals to a well-diversified portfolio.
Price Book 25.3678 | Enterprise Value Ebitda (2.20) | Price Sales 24.1807 | Shares Float 55.8 M | Wall Street Target Price 24.8571 |
Related Headline
Cns Pharmaceuticals Headline on 6th of February 2024
Purchase by Climaco John M of 166666 shares of Cns Pharmaceu... by Climaco John M
Filed transaction by Cns Pharmaceuticals Inc director. General open market or private purchase of non-derivative or derivative security
Phathom Pharmaceuticals Valuation on February 6, 2024
It is possible to determine the worth of Phathom Pharmaceuticals on a given historical date. On February 6, 2024 Phathom was worth 6.66 at the beginning of the trading date compared to the closed value of 7.08. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Phathom Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Phathom Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Phathom Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Phathom Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 6.85 | 6.85 | 6.49 | 6.68 | 606,990 | |
02/06/2024 | 6.66 | 7.20 | 6.61 | 7.08 | 755,483 |
| 7.16 | 7.26 | 6.79 | 7.23 | 1,665,138 |
| Backtest Phathom Pharmaceuticals | | | Phathom Pharmaceuticals History | | | Phathom Pharmaceuticals Valuation | Previous | Next |
Phathom Pharmaceuticals Trading Date Momentum on February 6, 2024
| On February 07 2024 Phathom Pharmaceuticals was traded for 7.23 at the closing time. The top price for the day was 7.26 and the lowest listed price was 6.79 . The trading volume for the day was 1.7 M. The trading history from February 7, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 2.12% . The trading delta at closing time against the current closing price is 3.39% . |
Phathom Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Phathom Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Phathom Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Phathom financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Phathom Pharmaceuticals Stock history
Phathom Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Phathom is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Phathom Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Phathom Pharmaceuticals stock prices may prove useful in developing a viable investing in Phathom Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 51.3 M | 35.6 M | |
| Net Loss | -178 M | -186.8 M |
Phathom Pharmaceuticals Quarterly Net Working Capital |
|
Phathom Pharmaceuticals Stock Technical Analysis
Phathom Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Phathom Pharmaceuticals Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Phathom Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Phathom Pharmaceuticals December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Phathom Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Phathom Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Phathom Pharmaceuticals stock market strength indicators, traders can identify Phathom Pharmaceuticals entry and exit signals to maximize returns
Phathom Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Phathom Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Phathom Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Phathom to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (0.88) | |||
| Total Risk Alpha | (1.77) | |||
| Treynor Ratio | (2.66) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Phathom Stock Analysis
When running Phathom Pharmaceuticals' price analysis, check to measure Phathom Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phathom Pharmaceuticals is operating at the current time. Most of Phathom Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Phathom Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phathom Pharmaceuticals' price. Additionally, you may evaluate how the addition of Phathom Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.